Andrew Bellinger

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Bellinger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 45,000 $450,000 $10.00 14 Feb 2024 Direct
Verve Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 180,000 14 Feb 2024 Direct

Insider Reports Filed by Andrew Bellinger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERV Verve Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Scientific Officer 16 Feb 2024, 16:30
VERV Verve Therapeutics, Inc. 14 Feb 2023 1 $0 4 CSO & CMO 16 Feb 2023, 16:00
VERV Verve Therapeutics, Inc. 14 Dec 2022 2 +$103,320 4 CSO & CMO 16 Dec 2022, 16:00
VERV Verve Therapeutics, Inc. 01 Dec 2022 1 -$19,852 4 CSO & CMO 02 Dec 2022, 16:00
VERV Verve Therapeutics, Inc. 28 Oct 2022 3 -$384,200 4 CSO & CMO 01 Nov 2022, 17:00
VERV Verve Therapeutics, Inc. 23 Sep 2022 8 -$2,031,592 4 CSO & CMO 27 Sep 2022, 17:00
VERV Verve Therapeutics, Inc. 20 Jul 2022 3 -$670,200 4 CSO & CMO 22 Jul 2022, 17:00
VERV Verve Therapeutics, Inc. 13 Jul 2022 3 -$234,200 4 CSO & CMO 15 Jul 2022, 17:00
VERV Verve Therapeutics, Inc. 11 Feb 2022 1 $0 4 Chief Scientific Officer 15 Feb 2022, 07:57
VERV Verve Therapeutics, Inc. 22 Dec 2021 5 -$558,269 4 Chief Scientific Officer 27 Dec 2021, 17:12
VERV Verve Therapeutics, Inc. 16 Dec 2021 1 $0 4 Chief Scientific Officer 17 Dec 2021, 15:41
VERV Verve Therapeutics, Inc. 17 Jun 2021 2 +$95,000 4 Chief Scientific Officer 21 Jun 2021, 18:21
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 Chief Scientific Officer 16 Jun 2021, 19:34